Your browser is no longer supported. Please, upgrade your browser.
ANIK Anika Therapeutics, Inc. daily Stock Chart
ANIK [NASD]
Anika Therapeutics, Inc.
Index- P/E14.65 EPS (ttm)1.90 Insider Own0.90% Shs Outstand15.11M Perf Week-4.98%
Market Cap420.51M Forward P/E14.11 EPS next Y1.97 Insider Trans-14.30% Shs Float13.60M Perf Month-35.14%
Income27.20M PEG1.46 EPS next Q0.06 Inst Own99.10% Short Float13.81% Perf Quarter-46.15%
Sales114.60M P/S3.67 EPS this Y48.40% Inst Trans0.13% Short Ratio8.72 Perf Half Y-50.36%
Book/sh20.18 P/B1.38 EPS next Y111.47% ROA8.70% Target Price62.00 Perf Year-8.42%
Cash/sh12.24 P/C2.27 EPS next 5Y10.00% ROE10.00% 52W Range22.01 - 75.71 Perf YTD-46.33%
Dividend- P/FCF12.30 EPS past 5Y-5.50% ROI8.80% 52W High-63.24% Beta1.17
Dividend %- Quick Ratio13.00 Sales past 5Y1.70% Gross Margin74.90% 52W Low26.44% ATR2.74
Employees154 Current Ratio14.40 Sales Q/Q10.40% Oper. Margin29.90% RSI (14)37.81 Volatility7.88% 11.06%
OptionableYes Debt/Eq0.00 EPS Q/Q-48.90% Profit Margin23.70% Rel Volume0.46 Prev Close29.68
ShortableYes LT Debt/Eq0.00 EarningsFeb 20 AMC Payout0.00% Avg Volume215.23K Price27.83
Recom1.00 SMA20-6.76% SMA50-25.67% SMA200-43.70% Volume98,019 Change-6.23%
Jan-21-20Upgrade Sidoti Neutral → Buy $61
Jan-10-20Upgrade First Analysis Sec Outperform → Strong Buy $65
Nov-05-19Initiated BWS Financial Sell $29
Sep-24-19Reiterated Barrington Research Outperform $49 → $58
Sep-23-19Downgrade First Analysis Sec Strong Buy → Outperform $54
Jul-25-19Upgrade First Analysis Sec Neutral → Strong Buy $37 → $54
Feb-22-19Downgrade Sidoti Buy → Neutral $56 → $41
Feb-22-19Downgrade First Analysis Sec Outperform → Neutral $41 → $37
Jul-27-18Upgrade Barrington Research Mkt Perform → Outperform $48
Jun-20-18Downgrade First Analysis Sec Overweight → Equal-Weight $45 → $34
Jun-20-18Downgrade Barrington Research Outperform → Mkt Perform
May-04-18Upgrade Barrington Research Mkt Perform → Outperform $39
Feb-23-18Downgrade Barrington Research Outperform → Mkt Perform
Jan-24-18Upgrade First Analysis Sec Equal-Weight → Overweight $45 → $68
Oct-27-17Reiterated Barrington Research Outperform $53 → $57
May-09-16Upgrade Singular Research BUY - Long-Term → Buy $60
Apr-27-16Downgrade Northland Capital Outperform → Market Perform
Feb-26-16Reiterated Barrington Research Outperform $45 → $49
Oct-12-15Initiated Barrington Research Outperform $39
Aug-28-15Initiated First Analysis Sec Equal-Weight
Apr-02-20 12:45PM  3 Benjamin Graham-Style Stocks GuruFocus.com
Mar-26-20 06:12AM  How Does Anika Therapeutics's (NASDAQ:ANIK) P/E Compare To Its Industry, After The Share Price Drop? Simply Wall St.
Mar-11-20 07:51AM  Can You Imagine How Anika Therapeutics's (NASDAQ:ANIK) Shareholders Feel About The 29% Share Price Increase? Simply Wall St.
Mar-04-20 08:30AM  Anika Appoints David Colleran as General Counsel Business Wire
Feb-27-20 07:52AM  New Strong Sell Stocks for February 27th Zacks
Feb-21-20 07:46AM  The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion Benzinga
Feb-20-20 07:15PM  Anika Therapeutics (ANIK) Beats Q4 Earnings and Revenue Estimates Zacks
04:05PM  Anika Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
Feb-13-20 12:31PM  Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-12-20 04:05PM  Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO GlobeNewswire
Feb-06-20 05:14PM  CORRECTING and REPLACING Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20 Business Wire
Feb-04-20 05:38AM  Do You Like Anika Therapeutics, Inc. (NASDAQ:ANIK) At This P/E Ratio? Simply Wall St.
Feb-03-20 04:30PM  Anika Therapeutics Closes Acquisition of Arthrosurface GlobeNewswire
Jan-29-20 04:30PM  Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer GlobeNewswire
Jan-24-20 04:05PM  Anika Therapeutics Closes Acquisition of Parcus Medical GlobeNewswire
Jan-13-20 03:00PM  Sale of Global Leader in Joint Preservation Incubated at Primo Medical Group PR Newswire
Jan-08-20 11:47AM  Massachusetts firm to acquire Sarasota sports medicine company for $35M American City Business Journals
Jan-06-20 08:30AM  Anika Therapeutics to Acquire Parcus Medical and Arthrosurface Business Wire
Dec-30-19 08:22AM  Anika Therapeutics, Inc. (NASDAQ:ANIK) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Dec-24-19 08:57AM  Sarepta (SRPT) Looks Good: Stock Adds 7.5% in Session Zacks
Dec-20-19 09:28AM  Bausch's (BHC) Arazlo Gets FDA Approval for Acne Vulgaris Zacks
Dec-19-19 11:35AM  Seattle Genetics Gets Speedy FDA Nod for Bladder Cancer Drug Zacks
10:18AM  Biotech Stock Outlook: M&A Activity Retains Growth Streak Zacks
10:02AM  Epizyme Stock Up on Positive Advisory Votes for Tazemetostat Zacks
Dec-17-19 10:25AM  Mallinckrodt Initiates Phase IV Study on Acthar for Keratitis Zacks
Dec-16-19 03:44PM  Pacira's Exparel Spurs Growth, Exclusive Reliance a Concern Zacks
09:46AM  Horizon Therapeutics Eye Drug Gets Positive FDA Advisory Vote Zacks
08:42AM  bluebird (BLUE) Catches Eye: Stock Jumps 6.8% Zacks
08:05AM  Biogen's Gosuranemab Fails in Phase II Brain Disorder Study Zacks
Dec-13-19 09:25AM  Blueprint Medicines (BPMC) Up More Than 30% YTD: Here's Why Zacks
Dec-12-19 03:19PM  ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study Zacks
02:34PM  BioCryst Submits NDA for Hereditary Angioedema Candidate Zacks
09:36AM  Amgen's Osteoporosis Drug Evenity Gets Approval in Europe Zacks
Dec-11-19 04:11PM  Is Anika Therapeutics, Inc. (ANIK) A Good Stock To Buy ? Insider Monkey
02:42PM  Vertex's Kalydeco Gets EU Approval to Treat CF in Infants Zacks
10:06AM  VistaGen Up on Fast Track Designation for Anxiety Disorder Drug Zacks
08:40AM  Intra-Cellular Therapies (ITCI) in Focus: Stock Moves 6.1% Higher Zacks
Dec-10-19 09:26AM  TG Therapeutics' Shares Soar on Positive Early-Stage Data Zacks
08:30AM  Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques Business Wire
Dec-09-19 04:31PM  Regeneron Reports Initial Data for Multiple Myeloma Drug Zacks
04:03PM  bluebird Reports Positive Top-Line Data on Myeloma Drug Zacks
08:36AM  Alexion (ALXN) Looks Good: Stock Adds 6% in Session Zacks
Dec-06-19 09:26AM  Sage Therapeutics' Depression Drug Fails in Study, Stock Down Zacks
Dec-05-19 03:53PM  Spero Posts Preliminary Data on SPR720 for Pulmonary Disease Zacks
10:02AM  Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug Zacks
09:07AM  Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon Zacks
Dec-04-19 10:25AM  Biogen's Lupus Candidate Meets Endpoint in Phase II Study Zacks
Dec-03-19 10:45AM  Seattle Genetics, Astellas Tie Up With Merck for Cancer Study Zacks
09:16AM  Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU Zacks
08:59AM  Puma Biotech Expands Pierre Fabre License to Add Countries Zacks
Dec-02-19 10:22AM  Acorda (ACOR) Down More Than 80% Year to Date: Here's Why Zacks
Nov-28-19 08:10AM  Incyte's NDA for Pemigatinib Gets FDA's Priority Review Tag Zacks
Nov-27-19 09:00AM  Clovis (CLVS) Looks Good: Stock Adds 6.3% in Session Zacks
03:32AM  Sorrento Turns Down Two All-Cash Takeover Bids, Stock Jumps Zacks
03:28AM  Global Blood's (GBT) Oxbryta Secures FDA Approval for SCD Zacks
Nov-25-19 09:18AM  Alexion Gets Approval for Label Expansion of Soliris in Japan Zacks
Nov-22-19 09:45AM  Biogen Ends Enrollment in Eye Disorder Study on Gene Therapy Zacks
Nov-21-19 10:24AM  Vertex (VRTX) Gets French Reimbursement for CF Drug Orkambi Zacks
09:54AM  Alnylam's Givosiran Gets FDA Nod for Acute Hepatic Porphyria Zacks
08:00AM  Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform GlobeNewswire
Nov-20-19 09:50AM  Achillion's (ACHN) Danicopan Gets EMA's PRIME Tag for PNH Zacks
Nov-19-19 09:40AM  Axovant's GM1 Gangliosidosis Candidate Gets Orphan Drug Tag Zacks
09:36AM  Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline Zacks
Nov-18-19 05:25PM  Celgene's Revlimid-Rituximab Combo Gets Positive CHMP Opinion Zacks
10:27AM  Medicines Company Posts Full Inclisiran Data From ASCVD Study Zacks
Nov-15-19 10:02AM  VistaGen's (VTGN) Major Depressive Disorder Drug Disappoints Zacks
09:10AM  Amarin (AMRN) Gets FDA Panel Nod for Vascepa Label Expansion Zacks
08:57AM  Sarepta (SRPT) Stock Down Despite New $48M Gene Therapy Deal Zacks
08:30AM  Anika Therapeutics Announces Participation in MEDICA International Trade Fair and International Cartilage Regeneration and Joint Preservation Society Focus Meeting Business Wire
Nov-14-19 10:20AM  BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
09:00AM  QIAGEN (QGEN) Catches Eye: Stock Jumps 9.9% Zacks
08:27AM  Halozyme Therapeutics (HALO) Looks Good: Stock Adds 5.4% in Session Zacks
Nov-13-19 09:05AM  Catalyst's (CPRX) Q3 Earnings Beat Estimates, Sales Miss Zacks
08:00AM  IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well Zacks
Nov-12-19 09:52AM  Amicus' (FOLD) Shares Rise on Q3 Earnings & Revenue Beat Zacks
Nov-09-19 03:54PM  Here is What Hedge Funds Think About Anika Therapeutics, Inc. (ANIK) Insider Monkey
Nov-08-19 10:08AM  Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis Zacks
Nov-07-19 11:26AM  PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales Zacks
11:20AM  Emergent (EBS) Beat Earnings in Q3, Vaccines Drive Sales Zacks
Nov-06-19 11:24AM  Blueprint Medicines (BPMC) Q3 Earnings & Sales Top Estimates Zacks
Nov-05-19 04:05PM  Anika to Showcase Joint Preservation and Restoration Portfolio at the 2019 Fortius International Sports Injury Conference Business Wire -6.17%
11:45AM  Acorda (ACOR) Q3 Earnings and Revenues Surpass Estimates Zacks
Nov-04-19 11:18AM  AMAG Q3 Loss Wider Than Expected, Revenues Lag Estimates Zacks
11:08AM  The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus Zacks
05:56AM  Does Anika Therapeutics, Inc. (NASDAQ:ANIK) Have A High Beta? Simply Wall St.
Nov-01-19 02:49PM  Repligen (RGEN) Beats on Q3 Earnings, Lifts 2019 Guidance Zacks
07:45AM  5 Top Momentum Stocks in October That Still Have Upside Left Zacks
Oct-31-19 12:40PM  Immunomedics (IMMU) Reports Wider-Than-Expected Loss in Q3 Zacks
12:33PM  Vertex (VRTX) Q3 Earnings Beat, Revenues Lag Estimates Zacks
Oct-30-19 10:00AM  What Makes Anika Therapeutics (ANIK) a Strong Momentum Stock: Buy Now? Zacks
Oct-29-19 10:27AM  Anika Therapeutics, Inc. (ANIK) Shares March Higher, Can It Continue? Zacks
Oct-25-19 07:12AM  The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug Benzinga +35.18%
Oct-24-19 06:45PM  Anika Therapeutics (ANIK) Q3 Earnings and Revenues Surpass Estimates Zacks
04:05PM  Anika Reports Third Quarter 2019 Financial Results Business Wire
Oct-18-19 11:17AM  Zacks.com featured highlights include: KB Home, Crocs, NetEase, Taylor Morrison Home and Anika Therapeutics Zacks
Oct-17-19 10:33AM  Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for Zacks
07:24AM  5 Stocks With Recent Price Strength Despite Trade Jitters Zacks
Oct-16-19 08:30AM  Anika to Showcase Joint Preservation and Restoration Portfolio at the Annual Scientific Meeting of the International Society for Hip Arthroscopy Business Wire
Oct-14-19 08:30AM  Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs Business Wire
Oct-10-19 04:05PM  Anika to Issue Third-quarter 2019 Financial Results and Business Highlights on Thursday, October 24 Business Wire
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a resorbable knitted fabric mesh; HYALOSS MATRIX, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAND RAYMOND JDirectorFeb 26Sale42.682,700115,23613,399Feb 27 06:54 PM
Cheung SylviaChief Financial OfficerNov 08Sale59.7120,0001,194,20047,741Nov 08 05:40 PM
Cheung SylviaChief Financial OfficerNov 06Option Exercise6.3635,000222,60071,422Nov 08 05:40 PM
Larsen Glenn R.DirectorAug 28Sale57.214,355249,1507,590Aug 30 04:05 PM
Bower Joseph L.DirectorAug 20Sale55.571,994110,80743,010Aug 22 04:05 PM
Thompson Jeffery SDirectorAug 08Sale56.664,843274,4046,842Aug 12 04:06 PM
LAND RAYMOND JDirectorJul 29Sale55.443,000166,32011,992Jul 30 04:06 PM